amble glp 1 Cares Program comment “amble” & I’ll dm
Description
Comparison between physiologic and erythromycin-induced interdigestive motility
AbbVie is investing in the development of novel GLP-1-based compounds and combination therapies to enhance weight loss efficacy
doi: 10.1001/jama.2019.2941 84 WenSNguyenTGongMYuanXWangCJinJet al
Wharton S, Davies M, Dicker D, et al
GLP-1s will increase health inequities
